What is the basic principle behind vaccine development? How do vaccines work? What approaches were adopted by the Indian vaccine manufacturers to produce COVID-19 vaccines?
Set out clearly how and why something works; here three linked parts must each be answered: the principle, the mechanism and the Indian manufacturing approaches.
Common trap: Most answers list vaccine names. A top answer links each Indian vaccine to its platform (inactivated, viral vector, DNA, protein subunit, mRNA) and explains why that platform triggers immunity.
SyllabusAwareness in the fields of IT, Space, Computers, robotics, nano-technology, bio-technology and issues relating to intellectual property rights.
Model answer
15 marks · 250-word limitA vaccine trains the immune system with a harmless copy or part of a pathogen so that the body remembers it and fights the real infection quickly. The idea dates to Edward Jenner's cowpox inoculation against smallpox in 1796; COVID-19 compressed a decade of vaccine science into one year.
- Vaccine delivers antigen (or its genetic code)
- Antigen-presenting cells display it
- Helper T cells activate B cells and killer T cells
- Antibodies and cytotoxic response clear antigen
- Memory B and T cells persist
- Rapid, strong response on real exposure
Basic principle of vaccine development
- Active acquired immunity: A vaccine mimics infection without causing disease, so the body produces its own antibodies and memory cells, unlike passive immunity from ready-made antibodies.
- Choice of antigen: Developers pick a safe trigger: a killed or weakened pathogen, a purified protein, or genetic instructions that make the host cells produce a viral protein such as the SARS-CoV-2 spike.
- Safety and efficacy testing: Candidates pass pre-clinical studies and Phase I, II and III trials before regulatory approval, in India by the CDSCO under the New Drugs and Clinical Trials Rules, 2019.
How vaccines work
- Primary response: Antigen-presenting cells show the antigen to T cells; B cells then make neutralising antibodies while killer T cells destroy infected cells.
- Immunological memory: Long-lived memory cells mount a faster and larger secondary response on later exposure, which is why booster doses are given.
- Herd immunity: When enough people are immune, transmission chains break and those who cannot be vaccinated are also protected.
Approaches adopted by Indian manufacturers
| Platform | Indian vaccine | How it was made |
|---|---|---|
| Whole-virion inactivated | Covaxin (Bharat Biotech with ICMR-NIV) | Virus strain isolated at NIV Pune, grown in Vero cells and chemically inactivated, with an adjuvant |
| Non-replicating viral vector | Covishield (Serum Institute of India) | Licensed Oxford-AstraZeneca design: chimpanzee adenovirus carrying the spike gene |
| Plasmid DNA | ZyCoV-D (Zydus Cadila) | World's first DNA vaccine for COVID-19, three doses by a needle-free applicator |
| Protein subunit | Corbevax (Biological E) | Receptor-binding domain protein made in yeast, developed with Baylor College of Medicine |
| mRNA | GEMCOVAC-19 (Gennova) | Self-amplifying mRNA, storable at 2-8 degrees C; emergency use approval in June 2022 |
| Intranasal vector | iNCOVACC (Bharat Biotech) | Adenovirus-vectored nasal drops, cleared for restricted emergency use in September 2022 |
- State support: Mission COVID Suraksha (2020) of the Department of Biotechnology through BIRAC funded candidates, and India crossed 200 crore doses on 17 July 2022, tracked on CoWIN.
India's COVID-19 response showed that platform diversity, public-private partnership and regulatory agility can turn the pharmacy of the world into a vaccine innovator. Sustaining it needs steady R&D funding, mRNA and nasal platforms ready for future pandemics, and stronger genomic surveillance.
Read more — sources
- NCERTBiology (Class XII) — Ch. 7, Human Health and Disease (immunity and vaccination)
- NCERTBiology (Class XII) — Ch. 10, Biotechnology and its Applications
- OfficialMinistry of Health and Family Welfare and Department of Biotechnology (PIB releases, 2021-22) on Mission COVID Suraksha and vaccine approvals
More from GS Paper 3 2022
Model answer by the EdiShorts editorial team. It is one well-argued treatment of the question, written to the official word limit — not an official UPSC answer key.